why choose us

First received: August 04, 2022

Clinical Trial: Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty

Study Status: Completed

Recruit Status: RECRUITING

Condition: Puberty; Precocious, Central

Study Type: INTERVENTIONAL


Official Title: An Open-label, Single Arm, Multicenter, Phase III Study on the Efficacy, Safety, and Pharmacokinetics of FP-001 42 mg Controlled Release in Patients With Central (Gonadotropin-Dependent) Precocious Pu

Brief Summary: The study will evaluate if Leuprolide Mesylate is safe and effective in the treatment of subjects with central (gonadotropin-dependent) precocious puberty, when administered as two injections six months apart.

Read more